News Search Results
Mar 20, 2025, 13:00 ET Nanoscope Therapeutics Announces the Appointment of Ademola Daramola, D.Sc., as Vice President, Quality & Compliance
Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal
More news about: Nanoscope Therapeutics
Mar 20, 2025, 12:00 ET Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025
human health and life, discover novel potential solutions, and realize those possibilities. " By combining expertise across medical AI, biotechnology, and embedded systems, Noul has commercialized miLab™, the world's first AI-powered diagnostic lab platform for point-of-care settings.
More news about: Noul
Mar 20, 2025, 12:00 ET Arkestro Welcomes Two New Executive Advisors To Support Ongoing Growth
is an experienced executive with a longstanding career spanning multiple industries, including automotive, e-commerce, metals, medical devices, biotechnology, life sciences, and pharmacy. Alan has previously held leadership roles in finance, operations, procurement, supply chain, and sales, directing
More news about: Arkestro
Mar 20, 2025, 11:29 ET Human Longevity, Inc. Pledges Bold $1 Million for Each Qualified Member Against Prostate Cancer
prostate cancer is caught early and treated effectively. About Human Longevity, Inc. Human Longevity, Inc. is a pioneering biotechnology company at the forefront of genomics, AI, and advanced medical technologies to extend healthspan and revolutionize preventative care. By leveraging
More news about: Human Longevity, Inc.
Mar 20, 2025, 09:00 ET Life Sciences and Nutrition Luminary Dr. Rob Sinnott joins Radicle Science as Senior Strategic Advisor
Radicle Science as Senior Strategic Advisor bolsters the company's innovation trajectory.Dr. Sinnott has over 25 years of experience in biotechnology, life sciences and nutrition; his past experiences include Chief Scientific Officer and CEO for Mannatech Inc., and Chief Scientific Officer for USANA
More news about: Radicle Science
Mar 20, 2025, 09:00 ET Coronado Research Announce the Appointment of Gary Lyons as EVP Medical Affairs
Coronado Research Coronado Research is a consultancy-led, professional services organisation, which provides support to pharmaceutical, biotechnology, and medical device companies. Our objective is to optimise the clinical development process by leveraging all the data available using AI, ML,
More news about: Coronado Research
Mar 20, 2025, 09:00 ET North Carolina Community College System Named Top 'Export Partner' in 2025 Governor's Awards
BioNetwork – Which offers education, training and laboratory resources tailored to the biotechnology and life sciences sectors. This includes critical training resources that ensure compliance with international regulations, improve product quality
More news about: North Carolina Community College System
Mar 20, 2025, 09:00 ET BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
Prescribing Information, including Boxed Warning. About BioMarin BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
More news about: BioMarin Pharmaceutical Inc.
Mar 20, 2025, 08:30 ET Bionova Scientific Appoints Bionique Testing Laboratories as Preferred Provider for Mycoplasma Testing Services for Biologics Manufacturing
overcoming discovery to first-in-human development challenges and scale-up. Bionova is a flexible and collaborative partner that has worked with leading biotechnology innovators from its new state-of-the-art facility in the San Francisco Bay Area. To learn more about Bionova, visit
More news about: Bionique Testing Laboratories LLC
Mar 20, 2025, 08:00 ET Makers of Visbiome Vet Earn NASC Quality Seal for Commitment to Excellence in Animal Health
ROCKVILLE, Md., March 20, 2025 /PRNewswire/ -- ExeGi Pharma, a biotechnology company specializing in probiotics for humans and pets, has been awarded the National Animal Supplement Council (NASC) Quality Seal, a designation
More news about: ExeGi Pharma
Mar 20, 2025, 08:00 ET Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options
Elevation Oncology cannot guarantee future events, results, actions, levels of activity, performance or achievements, and the timing and results of biotechnology development and potential regulatory approval are inherently uncertain. Forward-looking statements are subject to risks and uncertainties that may
More news about: Elevation Oncology
Mar 20, 2025, 07:31 ET MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update
March 20, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the year ended December 31,
More news about: MetaVia Inc.
Mar 20, 2025, 07:00 ET Marengo Therapeutics Enters Multi-Year Collaboration With University of Pennsylvania Institute for Immunology and Immune Health to Advance Next Wave Precision T Cell Immunology Research in Oncology and Autoimmune Diseases
March 20, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel discovery of reprogramming T cell repertoire for precision immunotherapy in oncology and autoimmune diseases, today announced
More news about: Marengo Therapeutics
Mar 20, 2025, 05:04 ET ICON Public Limited Company Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 11, 2025 to Discuss Your Rights - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: The Gross Law Firm
Mar 20, 2025, 04:30 ET Versameb AG Announces Grant of First Patent in China for "Signal Peptide with Heterologous Protein"
which a sling is permanently implanted into the urethra or bladder neck. About Versameb AG Versameb AG is a privately held biotechnology company focused on discovering and developing innovative RNA-based therapeutics. Founded in Basel in 2018, Versameb
More news about: Versameb AG
Mar 20, 2025, 04:30 ET Infinitopes Strengthens Board with Two Biotech Leaders to Advance Precision Immunotherapies into the Clinic
cancer centres in the first half of 2025. About Infinitopes Infinitopes Ltd is a soon to be clinical stage, integrated cancer biotechnology company supported by Cancer Research UK (CRUK) and the University of Oxford. The Company combines two world leading
More news about: Infinitopes
Mar 20, 2025, 03:31 ET Aquaporin announces full-year 2024 results
-- Aquaporin A/S (CSE: AQP) ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces the Annual Report for the period January 1 to December 31, 2024. "Notwithstanding the
More news about: Aquaporin A/S
Mar 20, 2025, 03:26 ET Aquaporin announces full-year 2024 results
-- Aquaporin A/S (CSE: AQP) ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces the Annual Report for the period January 1 to December 31, 2024. "Notwithstanding the
More news about: Aquaporin A/S
Mar 20, 2025, 03:00 ET Brainomix Completes £14M ($18M) Series C Round to Advance Its Transformative AI Imaging Technology in Healthcare
Ingelheim Venture Fund GmbHThe Boehringer Ingelheim Venture Fund (BIVF), established in 2010, is dedicated to investing in groundbreaking biotechnology companies that are at the forefront of therapeutic and digital innovations, aiming to advance biomedical research. With a commitment to revolutionizing
More news about: Brainomix
Mar 19, 2025, 23:41 ET BenQ Medical Technology and Brain Navi Align Partnership to Advance Neurosurgical Robotics in China
ZHUBEI, March 19, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, has announced a strategic partnership with BenQ Medical Technology to introduce and commercialize
More news about: Brain Navi
Mar 19, 2025, 19:12 ET ICLR Purchasers Have Opportunity to Lead ICON plc Securities Fraud Lawsuit
were insufficient to shield ICON from the adverse effects of a significant market downturn; (3) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: THE ROSEN LAW FIRM, P. A.
Mar 19, 2025, 13:30 ET Landmark Study Explains Why Obesity Drugs Work Differently for Women and Men
will help millions of women have a better solution without the side effects." About Olio Labs Olio Labs is a next-generation biotechnology company pioneering AI-driven therapeutic design. By fusing advanced computational methods with nuanced biological insights and cutting-edge technology,
More news about: Olio Labs
Mar 19, 2025, 12:00 ET ICON plc (ICLR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
offerings were insufficient to shield the Company from the adverse effects of a significant market downturn; (3) that the RFPs ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Law Offices of Howard G. Smith
Mar 19, 2025, 10:32 ET GenScript Unveils Prime Editing Boost with the Broad Institute Deal
N.J., March 19, 2025 /PRNewswire/ -- GenScript Biotech Corp., a global biotechnology leader in life science, biologics manufacturing, synthetic biology, and cell therapies, announced an exciting investment in gene editing technology.
More news about: GenScript Biotech Corporation
Mar 19, 2025, 10:00 ET Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T‑Cell Therapy Development
specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Eureka Therapeutics, Inc., a clinical-stage biotechnology company dedicated to developing novel T‑cell therapies for both solid tumors and hematologic malignancies.
More news about: Porton Advanced Solutions